# Filing Detail

Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-18-002913
Filing Date
2018-03-09
Accepted
2018-03-09 17:12:50
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS/A | 1834039
2 |  | filename2.htm | EX-21 | 2354
3 | GRAPHIC | g522368g19c10.jpg | GRAPHIC | 132105
4 | GRAPHIC | g522368g20i14.jpg | GRAPHIC | 131580
5 | GRAPHIC | g522368g29x80.jpg | GRAPHIC | 136035
6 | GRAPHIC | g522368g43z47.jpg | GRAPHIC | 83090
7 | GRAPHIC | g522368g47p15.jpg | GRAPHIC | 163623
8 | GRAPHIC | g522368g73n73.jpg | GRAPHIC | 47677
| Complete submission text file | 0000950123-18-002913.txt |  | 2794228

Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 1 (872) 225-6077
Iterum Therapeutics Ltd (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01913 | Film No.: 18680995
SIC: 2834 Pharmaceutical Preparations